Cutaneous T cell lymphoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
Conditions: Cutaneous T-Cell Lymphoma Interventions: Diagnostic Test: Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / S ézary syndrome (SS). Sponsors: Instituto de Investigaci ón Biomédica de Salamanca; Carlos III Health Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or S ézary Syndrome Previously Treated With Systemic Therapy
Conditions: Cutaneous T-Cell Lymphoma Interventions: Drug: Mogamulizumab Sponsors: Kyowa Kirin China Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
Conditions: Mycosis Fungoides Interventions: Drug: Mogamulizumab-Kpkc; Device: Phototherapy Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Kyowa Hakko Kirin Pharma, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
Conditions: Lymphomatoid Papulosis; Mycosis Fungoides Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides Interventions: Drug: Hypericin; Drug: Mechlorethamine Topical Gel Sponsors: Soligenix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma: a Multicenter Observational Study
Conditions: Cutaneous T Cell Lymphoma; Cutaneous T-Cell Lymphoma/Mycosis Fungoides; Cutaneous T-Cell Lymphoma/Sezary Syndrome Sponsors: Fondazione Italiana Linfomi - ETS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
Conditions: Cutaneous T Cell Lymphoma; Cutaneous T-Cell Lymphoma/Mycosis Fungoides; Cutaneous T-Cell Lymphoma/Sezary Syndrome Sponsors: Fondazione Italiana Linfomi - ETS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

Kymera Therapeutics Receives U.S. FDA Fast Track Designation for KT-333, a First-in-Class, Investigational STAT3 Degrader for the Treatment of Relapsed/Refractory Cutaneous T-Cell Lymphoma and Relapsed/Refractory Peripheral T-Cell Lymphoma
KT-333 Phase 1 oncology trial ongoing with an update including initial evaluation of its clinical antitumor activity in patients expected in the fourth quarter of 2023 Fast Track designation can potentially accelerate KT-333’s development... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 18, 2023 Category: Pharmaceuticals Source Type: clinical trials

Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study
Condition: Cutaneous T-cell Lymphoma Intervention: Drug: Linperlisib in combined with Chidamide Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials